A Lloyd's of London company partnered with GATC Health to fund and insure prospective drug trials that pass the test of a new ...

Peter Thiel-backed Lindus Health has raised $55 million as it sets about "fixing the broken clinical trial industry." ...

Discover how precision medicine and FDA's Project Optimus are transforming clinical trials in oncology drug development.

A temporary freeze on meetings on the National Institutes of Health could lead to delays in disbursing research grants and in ...

The IRA’s price controls discourage post-marketing research. The potential benefits from expanding access to the drug to ...

Two new studies have identified a possible way to block the progression of several forms of blood cancer using a drug already in clinical trials against breast cancer.

Google DeepMind spinoff Isomorphic Labs expects testing on its first AI-designed drugs to begin this year, as tech startups ...

An Alphabet-backed startup is poised to begin clinical trials of its first artificial intelligence-designed drug by year-end.

With each new year comes a new set of accompanying challenges, from tackling the latest innovations to new incarnations of old issues. 2025 will be ...

On January 6, 2025, the U.S. Food and Drug Administration (FDA) released draft guidance titled Considerations for the Use of Artificial ...

N-Power Medicine, a company leading the reinvention of the clinical trial process, today announced the acquisition of Syapse ...